HIPEC Combo Doubles PFS in Advanced Ovarian Cancer

(MedPage Today) -- Two drugs outperformed one for hyperthermic intraperitoneal chemotherapy (HIPEC) after interval surgical debulking of advanced ovarian cancer, data from a prospective registry showed.
Median progression-free survival (PFS) doubled...